Trial
NCT01721577
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Rush University Medical Center
Collaborators
Axelar AB
Condition
Glioblastoma
Intervention
AXL1717
Why stopped
Investigator went to another institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-22